Stocks / NASDAQ / Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc.

Our Opinion

Karuna Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

In the following press release company mentioned the usage of animals for drug testing.

“We believe that these preclinical data of xanomeline in various animal pain models and other published results linking stimulation of muscarinic receptors to analgesia highlight the potential for KarXT to have therapeutic benefit in patients experiencing various types of pain including post-operative, inflammatory and neuropathic pain.” Read the full article

Company Description

Company Website: